4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-085677
Principal Accounting Officer sold 25,700 shares at an average $18.09 ($464,886)
- Principal Accounting Officer acquired 25,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunn Edmund Principal Accounting Officer | 2026-02-27 | Option exercise | +25,164 | $13.41 | $337,449 | 47,857 | D: show line 1 in the form |
| Dunn Edmund Principal Accounting Officer | 2026-02-27 | Sale | −25,164 | $18.10 | $455,506 | 22,693 | D: show line 2 in the form |
| Dunn Edmund Principal Accounting Officer | 2026-03-02 | Option exercise | +536 | $13.41 | $7,188 | 23,229 | D: show line 3 in the form |
| Dunn Edmund Principal Accounting Officer | 2026-03-02 | Sale | −536 | $17.50 | $9,380 | 22,693 | D: show line 4 in the form |
| Open-market sales · 25,700 sh · avg $18.09 · $464,886 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dunn Edmund Principal Accounting Officer | 2026-02-27 | Option exercise · Stock Option (Right to Buy) | −25,164 | 536 | D: show line 5 in the form | |||||
| Dunn Edmund Principal Accounting Officer | 2026-03-02 | Option exercise · Stock Option (Right to Buy) | −536 | 0 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…